120.31

0.88% 1.07

Jazz Pharmaceuticals Plc (JAZZ)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$119.24

Offen:

$121.84

24-Stunden-Volumen:

91,901

Relative Volume:

0.14

Marktkapitalisierung:

$7.21B

Einnahmen:

$3.91B

Nettoeinkommen (Verlust:

$394.92M

KGV:

-76.63

EPS:

-1.57

Netto-Cashflow:

$1.02B

1W Leistung:

-3.20%

1M Leistung:

+6.34%

6M Leistung:

+12.45%

1J Leistung:

+1.71%

1-Tages-Spanne:

$120.07

$122.03

1-Wochen-Bereich:

$115.65

$123.19

52-Wochen-Spanne:

$99.06

$134.17

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Firmenname

Jazz Pharmaceuticals Plc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

353-1-634-7800

Adresse

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Mitarbeiter

2,800

Twitter

@jazzpharma

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

JAZZ's Discussions on Twitter

Vergleichen Sie JAZZ mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
JAZZ	120.22	7.21B	3.91B	394.92M	1.02B	-1.57
VRTX	445.81	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	735.95	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	584.00	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.73	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.25	24.49B	3.30B	-501.07M	1.03B	11.54

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-01-03	Eingeleitet	Robert W. Baird	Outperform
2023-11-27	Herabstufung	UBS	Buy → Neutral
2023-09-29	Eingeleitet	Raymond James	Mkt Perform
2023-06-12	Fortgesetzt	Wells Fargo	Equal Weight
2022-12-09	Hochstufung	Goldman	Neutral → Buy
2022-06-14	Eingeleitet	UBS	Buy
2022-04-06	Herabstufung	Goldman	Buy → Neutral
2021-11-19	Fortgesetzt	Goldman	Buy
2021-10-07	Fortgesetzt	Jefferies	Buy
2021-10-05	Eingeleitet	Citigroup	Buy
2021-09-23	Eingeleitet	Needham	Buy
2021-05-19	Fortgesetzt	JP Morgan	Overweight
2021-04-07	Fortgesetzt	RBC Capital Mkts	Outperform
2021-02-05	Bestätigt	H.C. Wainwright	Buy
2021-02-03	Hochstufung	Piper Sandler	Neutral → Overweight
2021-01-29	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-12-16	Eingeleitet	UBS	Buy
2020-11-03	Bestätigt	H.C. Wainwright	Buy
2020-10-09	Bestätigt	H.C. Wainwright	Buy
2020-09-14	Herabstufung	Goldman	Neutral → Sell
2020-09-14	Fortgesetzt	JP Morgan	Overweight
2020-08-06	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-07-28	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-07-23	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-04-06	Eingeleitet	Jefferies	Buy
2020-03-12	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-01-08	Eingeleitet	Goldman	Neutral
2019-08-21	Herabstufung	Piper Jaffray	Overweight → Neutral
2019-06-11	Eingeleitet	Barclays	Overweight
2019-03-20	Eingeleitet	SunTrust	Buy
2018-12-14	Eingeleitet	Wolfe Research	Peer Perform
2018-11-08	Bestätigt	B. Riley FBR	Buy
2018-08-08	Bestätigt	Stifel	Buy
2018-07-11	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-03-23	Bestätigt	H.C. Wainwright	Neutral
2018-03-19	Hochstufung	Morgan Stanley	Equal-Weight → Overweight

Alle ansehen

Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten

09:09 AM

Pacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

09:09 AM

08:57 AM

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga

08:57 AM

08:10 AM

John G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

08:10 AM

06:53 AM

Jazz stock Zymeworks stock gain on FDA nod (JAZZ:NASDAQ) - Seeking Alpha

06:53 AM

06:00 AM

Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan

06:00 AM

01:33 AM

JAZZ (Jazz Pharmaceuticals) COGS-to-Revenue : 0.11 (As of Sep. 2024) - GuruFocus.com

01:33 AM

Nov 20, 2024

Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters.com

Nov 20, 2024

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - JAZZ's Investor Relations

Nov 20, 2024

Nov 19, 2024

Jazz Pharmaceuticals to Present at Citi's 2024 Global Healthcare Conference | JAZZ Stock News - StockTitan

Nov 19, 2024

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? - Yahoo Finance

Nov 19, 2024

Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment - Insider Monkey

Nov 19, 2024

Nov 18, 2024

Jazz Pharmaceuticals: High Uncertainty, Low Risk (undefined:JAZZ) - Seeking Alpha

Nov 18, 2024

Jazz Pharmaceuticals shares target raised on patient base growth By Investing.com - Investing.com UK

Nov 18, 2024

Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? - Insider Monkey

Nov 18, 2024

Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. Baird - MarketBeat

Nov 18, 2024

Victory Capital Management Inc. Has $28.22 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 18, 2024

Nov 17, 2024

Jazz Tops Q3 Earnings & Sales Estimates, Raises '24 EPS View - MSN

Nov 17, 2024

Los Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Jazz Pharmaceuticals Plc: Its Efforts Towards Zepzelca Frontline Therapy Expansion & Other Major Drivers - Smartkarma

Nov 16, 2024

KBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024

Principal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Idiopathic Hypersomnia Treatment Market will experience - openPR

Nov 15, 2024

Nov 14, 2024

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? - Yahoo Finance

Nov 14, 2024

We Think Jazz Pharmaceuticals' (NASDAQ:JAZZ) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St

Nov 14, 2024

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Nov 14, 2024

Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares By Investing.com - Investing.com Australia

Nov 14, 2024

Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $175.00 - MarketBeat

Nov 14, 2024

Nov 13, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kovack Advisors Inc. - MarketBeat

Nov 13, 2024

Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? - Yahoo Finance

Nov 13, 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

American Assets Inc. Invests $557,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 11, 2024

Jazz Pharmaceuticals plc Updates Earnings Guidance for the Full Year 2024 - Marketscreener.com

Nov 11, 2024

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Nov 11, 2024

Nov 10, 2024

28,693 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by CWA Asset Management Group LLC - MarketBeat

Nov 10, 2024

Amalgamated Bank Sells 9,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 10, 2024

Nov 08, 2024

Philip James Wealth Mangement LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Van ECK Associates Corp Increases Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024

Nov 07, 2024